{"denoms":[{"counts":[{"groupId":"BG000","value":"33"}],"units":"Participants"}],"groups":[{"description":"Participants received denosumab at a dose of 120 mg subcutaneously (SC) every 4 weeks (Q4W) with a loading dose of 120 mg SC on study Days 8 and 15.","id":"BG000","title":"Denosumab"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"14.8","value":"60.3"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"21"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"23"}]}],"title":"White or Caucasian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Black or African American"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Hispanic or Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Other"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"title":"2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":"3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"4"}],"description":"Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about \\> 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair \\> 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.","paramType":"NUMBER","title":"Eastern Cooperative Oncology Group (ECOG) Performance Status","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Bladder"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"Breast"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Head and neck"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Liver"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Neuroendocrine/carcinoid"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Non-hodgkin's"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Non-small cell lung cancer"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Ovarian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Renal"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Small cell lung cancer"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Soft tissue sarcoma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Unknown (primary tumor)"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Multiple myeloma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Chronic lymphocytic leukemia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"IGG kappa multiple myeloma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Myeloma"}],"paramType":"NUMBER","title":"Primary Tumor Type","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"68.8","value":"56.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Time from initial cancer diagnosis to enrollment","unitOfMeasure":"months"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"30"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"No"}],"paramType":"NUMBER","title":"Presence of metastatic disease at enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"20"}]}],"title":"No"}],"paramType":"NUMBER","title":"Presence of bone metastatic disease at enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}],"title":"Fatigue"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"Anorexia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Nausea"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Depressed level of consciousness"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Vomiting"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Dry mouth"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Constipation"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Lethargy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Confusion"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Polyuria"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Abdominal pain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Decreased mental acuity"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Dyspnea"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"General weakness"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Insomnolence"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Light headedness (dizziness)"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Listlessness/muscle weakness"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Polyuro-polydipsic syndrome"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Psychomotor retardation"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Retching"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Urinary frequency"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Weight loss"}],"description":"Participants may have had more than one symptom","paramType":"NUMBER","title":"Baseline Hypercalcemia of Malignancy (HCM) Symptoms","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"1.27","value":"13.89"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Calcium (corrected)","unitOfMeasure":"mg/dL"}]}